B

BL Corp
KOSDAQ:142760

Watchlist Manager
BL Corp
KOSDAQ:142760
Watchlist
Price: 1 755 KRW -3.25% Market Closed
Market Cap: ₩68.5B

Operating Margin

-75.3%
Current
Declining
by 44.6%
vs 3-y average of -30.6%

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
-75.3%
=
Operating Income
₩-7.4B
/
Revenue
₩9.8B

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
-75.3%
=
Operating Income
₩-7.4B
/
Revenue
₩9.8B

Peer Comparison

Country Company Market Cap Operating
Margin
KR
BL Corp
KOSDAQ:142760
68.5B KRW
Loading...
FR
Pharnext SCA
OTC:PNEXF
6T USD
Loading...
US
Abbvie Inc
NYSE:ABBV
385B USD
Loading...
US
Amgen Inc
NASDAQ:AMGN
184.4B USD
Loading...
US
Gilead Sciences Inc
NASDAQ:GILD
169B USD
Loading...
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
118.3B USD
Loading...
US
Epizyme Inc
F:EPE
94.1B EUR
Loading...
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
79.1B USD
Loading...
AU
CSL Ltd
ASX:CSL
87B AUD
Loading...
NL
argenx SE
XBRU:ARGX
43.2B EUR
Loading...
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
47.8B USD
Loading...

Market Distribution

Lower than 94% of companies in Korea
Percentile
6th
Based on 2 615 companies
6th percentile
-75.3%
Low
-163 055.6% — -2.2%
Typical Range
-2.2% — 6.8%
High
6.8% — 22 874.8%
Distribution Statistics
Korea
Min -163 055.6%
30th Percentile -2.2%
Median 2.7%
70th Percentile 6.8%
Max 22 874.8%

BL Corp
Glance View

Market Cap
68.5B KRW
Industry
Biotechnology

BL Corp. engages in the development of biopharmaceutical products. The company is headquartered in Yongin, Gyeonggi-Do. The company went IPO on 2014-11-26. The firm is engaged in the manufacture and sale of health functional foods and functional cosmetics. In addition, the Company is engaged in the distribution of pharmaceuticals and medical supplies. The firm is engaged in the distribution of Glu 100 Tablets, CellribonQ, and GentaQ and other medicine to general hospitals and pharmacies.

Intrinsic Value
1 044.32 KRW
Overvaluation 40%
Intrinsic Value
Price
B
What is Operating Margin?
Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.
How is Operating Margin calculated?

Operating Margin is calculated by dividing the Operating Income by the Revenue.

Operating Margin
-75.3%
=
Operating Income
₩-7.4B
/
Revenue
₩9.8B
What is BL Corp's current Operating Margin?

The current Operating Margin for BL Corp is -75.3%, which is below its 3-year median of -30.6%.

How has Operating Margin changed over time?

Over the last 3 years, BL Corp’s Operating Margin has decreased from -15.3% to -75.3%. During this period, it reached a low of -75.3% on Oct 30, 2025 and a high of -11% on Sep 30, 2023.

Back to Top